Vividrin Eye Drops 2% sodium cromoglicate (2007)
Βιβλιογραφική αναφορά
Στοιχεία εκδότη
Εκδότης | Bausch & Lomb U.K Limited |
---|---|
Διεύθυνση | Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK |
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Name of the medicinal product
Vividrin Eye Drops. Vividrin Hay Fever Eye Drops.
Qualitative and quantitative composition
Active: Sodium cromoglycate EP 2.00% w/v.
Pharmaceutical form
Sterile Preserved Multidose Eye Drops.
Therapeutic indications
Vividrin Eye Drops are for the prophylaxis and symptomatic treatment of acute allergic conjunctivitis, chronic allergic conjunctivitis and vernal kerato conjunctivitis. Vividrin Hay Fever Eye Drops are ...
Posology and method of administration
Route of Administration: For topical administration to the eye. Adults, Children and the Elderly One or two drops into each eye up to four times daily.
Contraindications
Known hypersensitivity to benzalkonium chloride, sodium cromoglycate or other constituents.
Special warnings and precautions for use
The solution should be discarded 1 month after first opening the bottle or if any turbidity develops. Do not use if the bottle has been opened prior to receipt. Vividrin Eye Drops and Vividrin Hay Fever ...
Interaction with other medicinal products and other forms of interaction
None known.
Pregnancy and lactation
Use in Pregnancy: Vividrin Eye Drops and Vividrin Hay Fever Eye Drops should be used cautiously during pregnancy and lactation. The widespread use of sodium cromoglycate has yet to reveal any adverse effects ...
Effects on ability to drive and use machines
Transient stinging or blurred vision may occur on instillation. Do not drive or operate machinery until proper vision is restored.
Undesirable effects
Transient stinging and burning may occur after instillation, other symptoms of local irritation have been reported rarely.
Overdose
As sodium cromoglycate is absorbed only to a very limited extent from eye drops, no action other than medical observation should be necessary.
Pharmacodynamic properties
Sodium cromoglycate has neither anti-histaminic or anti-inflammatory activity. Evidence suggests that sodium cromoglycate inhibits the release of mediators of the allergic reaction by stabilising the membranes ...
Pharmacokinetic properties
Due to lipid insolubility, sodium cromoglycate is poorly absorbed following administration to the eye. In normal volunteers approximately 0.03% is systemically absorbed. Absorbed sodium cromoglycate is ...
Preclinical safety data
The results of the studies do not add to the information needed by the prescriber, consequently, they are not repeated in the SPC.
List of excipients
Benzalkonium chloride EP Edetic acid disodium salt 2H2O EP Polysorbate 80 EP Sorbitol EP Sodium hydroxide EP Purified water EP
Incompatibilities
Sodium cromoglycate forms insoluble complexes with metal ions resulting in solution turbidity.
Shelf life
Unopened: 36 months. Once opened for the first time: 1 month.
Special precautions for storage
Store below 25ºC, out of direct sunlight.
Nature and contents of container
Vividrin Eye Drops – 13.5ml polyethylene multidose eye dropper bottle with polyethylene cap. Vividrin Hay Fever Eye Drops – 10.0ml polyethylene multidose eye dropper bottle with polyethylene cap.
Special precautions for disposal and other handling
The following instructions for use are included in the patient leaflet: Before using your Vividrin Eye Drops (Vividrin Hay Fever Eye Drops) you should wash your hands. You may find it helps to sit in front ...
Marketing authorization holder
Pharma Global Limited Hudson Road Sandycove Co Dublin Ireland
Marketing authorization number(s)
PL 11185/0004
Date of first authorization / renewal of the authorization
13th December 1996
Date of revision of the text
Not applicable.